Characterization of Alterations of Hemodynamics and Neuroendocrine Hormones in Dexamethasone Induced Hypertension in Dogs

References

• Whitworth J A. Mechanisms of glucocorticold-induced hypertension. Kidney Int. 1987; 31: 1213–1224
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez C E. Cushing's syndrome and hypertension. Hypertension 1986; 8: 258–264
   PubMed Web of Science ®Google Scholar
• Hall J E, Morse C L, Smith M J, Young D B, Guyton A C. Control of arterial pressure and renal function during glucocorticoid excess in dogs. Hypertension 1980; 2: 139–148
   PubMed Web of Science ®Google Scholar
• Okuno T, Suzuki H, Saruta T. Dexamethasone hypertension in rats. Clin Exp Hypertens. 1981; 3: 1075–1086
   PubMed Web of Science ®Google Scholar
• Suzuki H, Handa M, Kondo K, Saruta T. Role of renin-angiotensin system in glucocorticoid hypertension in rats. Am J Physiol. 1982; 243: E48–E51
   PubMed Web of Science ®Google Scholar
• Handa M, Kondo K, Suzuki H, Saruta T. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats. Clin Sci. 1983; 65: 37–42
   PubMed Web of Science ®Google Scholar
• Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 1984; 6: 236–241
   PubMed Web of Science ®Google Scholar
• Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 1986; 62: 275–279
   PubMed Web of Science ®Google Scholar
• Dalakos T G, Elias A N, Anderson G H, Jr., Streeten D HP, Schroeder E T. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome. J Clin Endocrinol Metab. 1978; 46: 114–118
   PubMed Web of Science ®Google Scholar
• Krakoff L R, Selvadurai R, Sutter E. Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat. Am J Physiol. 1975; 228: 613–617
   PubMed Web of Science ®Google Scholar
• Ganong W F. Review of Medical Physiology, W F Ganong. Lange Medical Publication, California 1987; 297–320
   Google Scholar
• Whitworth J A, Gordon D, Andrews J, Scoggins B A. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens. 1989; 7: 537–549
   PubMed Web of Science ®Google Scholar
• Nakamoto H, Suzuki H, Murakami M, Kageyama Y, Ohishi A, Fukuda K, Hori S, Saruta T. Effects of endothelin on systemic and renal hemodynamics and neuroendocrine hormones in conscious dogs. Clin Sci. 1989; 77: 567–572
   PubMed Web of Science ®Google Scholar
• Murakami M, Suzuki H, Nakajima S, Nakamoto H, Kageyama Y, Saruta T. Calcitonin gene-related peptide is an inhibitor of aldosterone secretion. Endocrinol. 1989; 125: 2227–2229
   PubMed Web of Science ®Google Scholar
• Haber E, Koerner T, Page L B, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969; 29: 1349–1355
   PubMed Web of Science ®Google Scholar
• Ogihara T, Iinuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y. A non-chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab. 1977; 45: 726–731
   PubMed Web of Science ®Google Scholar
• Saito T, Yamaji Y, Watanabe T. Antidiuretic hormone, S Yoshida, L Share, K Yagi. University Park Press, Baltimore 1981; 215–225
   Google Scholar
• Nakajima S, Suzuki H, Kageyama Y, Takita T, Saruta T. Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis. Acta Endocrinol. 1988; 119: 257–262
   PubMedGoogle Scholar
• Tsuei S E, Moore R G, Ashley J J, McBride W G. Disposition of synthetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults. J Pharmacokinet Biopharm. 1979; 7: 249–264
   PubMedGoogle Scholar
• Peach M J. Renin-angiotensin system: Biochemistry and mechanism of action. Physiol Rev. 1977; 57: 313–370
   PubMed Web of Science ®Google Scholar
• Stuzmann M, Radziwill R, Komischke K, Klett C, Hackenthal E. Hormonal and pharmacological alteration of angiotensinogen secretion from rat hepatocytes. Biochim Biophys Acta. 1986; 886: 48–56
   PubMed Web of Science ®Google Scholar
• Mendlowitz M, Naftchi N, Weinreb H L, Gitlow S E. Effect of prednisolone on digital vascular reactivity in normotensive and hypertensive subjects. J Appl Physiol. 1961; 16: 89–94
   PubMed Web of Science ®Google Scholar
• Rascher W, Schomig A, Dietz R, Weber J, Gross F. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats. Eur J Pharmacol. 1981; 75: 255–263
   PubMed Web of Science ®Google Scholar
• Waeber B, Gavras H, Bresnahan M R, Gavras I, Brunner H R. Role of vasoconstrictor systems in experimental glucocorticoid hypertension in rats. Clin Sci. 1983; 65: 255–261
   PubMed Web of Science ®Google Scholar
• Besse J C, Bass A D. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle. J Pharmacol Exp Ther. 1966; 154: 224–238
   PubMed Web of Science ®Google Scholar
• Kalsner S. Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res. 1969; 24: 383–395
   PubMed Web of Science ®Google Scholar
• Pamnani M B, Clough D L, Haddy F J. Altered activity of the sodium-potassium pump in arteries of rats with steroid hypertension. Clin Sci Mol Mod. 1978; 55: 41s–43s
   PubMedGoogle Scholar
• Sklar A H, Schrier R W. Central nervous system mediators of vasopressin release. Physiol Rev. 1983; 63: 1243–1280
   PubMed Web of Science ®Google Scholar
• Ramos-Frendo B, Eloy L, Grunfeld J P. Methylprednisolone induced hypertension in the rat: evidence against the role of plasma volume changes, vasopressin and renal prostaglandin E2. J Hypertens. 1985; 3: 461–467
   PubMed Web of Science ®Google Scholar
• Yasujima M, Abe K, Tanno M, Kohzuki M, Kanazawa M, Omata K, Kasai Y, Sato M, Takeuchi K, Itoh S, Hiwatari M, Saito T, Sano S, Yoshinaga K. Long-term effects of aldosterone on kallikrein, prostaglandin E2 and sodium in rats. Tohoku J Exp Med. 1987; 152: 351–362
   PubMed Web of Science ®Google Scholar
• Marusic E T, Hayslett J P, Binder H J. Corticosteroid-binding studies in cytosol of colonic mucosa of the rat. Am J Physiol. 1981; 240: G417–G423
   PubMed Web of Science ®Google Scholar
• Dworkin L D, Ichikawa I, Brenner B M. Hormonal modulation of glomerular function. Am J Physiol. 1983; 244: F95–F104
   PubMed Web of Science ®Google Scholar
• Arndshorst W, Navar L G. Diseases of the Kidney, R W Schrier, C W Gottshcalk. Little Brown, Boston 1979; 65–117
   Google Scholar
• Raine A EG, Firth J G, Ledingham J GG. Renal action of atrial natriuretic factor. Clin Sci. 1989; 76: 1–8
   PubMed Web of Science ®Google Scholar
• Gardner D G, Hane S, Trachewsky D, Schenk D, Baxter J D. Atrial natriuretic peptide mRNA is regulated by glucocorticoid in vivo. Biochem Biophys Res Commun. 1986; 139: 1047–1054
   PubMed Web of Science ®Google Scholar
• Saxenhofer H, Angst M, Weidmann P, Shaw S G, Ferrier C. Corticosteroid-induced stimulation of atrial natriuretic peptide in man. Acta Endocrinol. 1988; 118: 179–186
   PubMedGoogle Scholar